Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Metabolic Risk Equipment Supplied In Europe
4 equipment items found
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
Mutations in the methylenetetrahydrofolate reductase (MTHFR) gene are associated with decreased enzyme activity, which leads to hyperhomocysteinemia and toxic side effects of methotrexate therapy. ViennaLab assays identify patients predisposed to develop cardiovascular diseases or intolerance to ...
Manufactured by:BrainCool AB based inLund, SWEDEN
The Cooral System offers a big step forward in improving the quality of life for patients by providing medical professionals an easy way to reduce the risk of oral mucositis (mouth sores). The Cooral System is a novel and unique solution innovated by CoolPrevent, a leading medical cooling systems ...
Manufactured by:LMA Airway Management abrand of Teleflex Incorporated based inAthlone, IRELAND
The unique design of MAD Nasal™ enables a seal to be formed with the nostril and atomized particles of medication to be delivered to the nasal mucosa. The particles are then absorbed through the mucosal tissue and into the bloodstream, avoiding first pass metabolism. ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for disease progression, who would be ...